Intrinsic Therapeutics, Inc. Company Profile

10:49 EDT 25th March 2019 | BioPortfolio

Intrinsic Therapeutics is dedicated to treating soft-tissue injuries of the spine. Intrinsic's Barricaid anular reconstructive products are used during discectomy to definitively close defects in the posterior anulus. By restoring anular competence, the Barricaid family of products may reduce the risk of recurrent herniation while maintaining disc height and biomechanics.

News Articles [831 Associated News Articles listed on BioPortfolio]

Intrinsic Clinical Systems Announces Release of Time Tracking Tool, Intrinsic InTime

PHILADELPHIA (PRWEB) October 16, 2018 Intrinsic released its time tracking tool, InTime, as part of its mission to provide simple,...

Origin of resistance to lung-cancer drug discovered

(Kanazawa University) Researchers at Kanazawa University report in Nature Communications what causes some lung-cancer patients to have an intrinsic resistance to the drug osimertinib: AXL, a protein b...

Intrinsic Clinical Systems to Host Webinar Featuring Resource Management and Time Tracking Tools, Insights RM & InTime

Intrinsic Clinical Systems will host a free webinar on March 27, 2019 at 12PM EDT featuring its web-based resource management system, Insights RM, and its time tracking tool, InTime. The tools were de...

Recently launched start-up Anthos licenses Novartis' MAA868 anti-thrombotic candidate

Recently launched Anthos Therapeutics Inc. in-licensed Novartis AG's MAA868, an antibody directed at clotting protein Factors XI and XIa (genetic and pharmacological components of the intrinsic coagul...

Correction to: NFATc2 is an intrinsic regulator of melanoma dedifferentiation

BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors

Understanding the intrinsic radioactivity energy spectrum from 176Lu in LYSO/LSO scintillation crystals

An IRAK1–PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy

Drugs and Medications [35 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]


Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Enlyte [jaymac pharmaceuticals llc]

EnLyte with DeltaFolate

Enbrace hr [jaymac pharmaceuticals, llc]

EnBrace HR™ Multiphasic Soft Gelatin Capsules

Oxygen [breathe easy therapeutics, inc]


PubMed Articles [745 Associated PubMed Articles listed on BioPortfolio]

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Does instrumental motivation help students with low intrinsic motivation? Comparison between Western and Confucian students.

The research examines possible differences in the mutual reinforcement (i.e. multiplicative) effect between intrinsic and instrumental motivation on academic performance across different cultures. Eig...

Plasticity of intrinsic neuronal excitability.

Long-term synaptic modification is not the exclusive mode of memory storage, and persistent regulation of voltage-gated ion channels also participates in memory formation. Intrinsic plasticity is expr...

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

Differential Gene Expression Common to Acquired and Intrinsic Resistance to BRAF Inhibitor Revealed by RNA-Seq Analysis.

Melanoma cells have been shown to respond to BRAF inhibitors; however, intrinsic and acquired resistance limits their clinical application. In this study, we performed RNA-Seq analysis with BRAF inhib...

Clinical Trials [374 Associated Clinical Trials listed on BioPortfolio]

Serum Hepcidin Immunoassay - Laboratory to Marketplace

This is a single center, prospective, observational study to demonstrate the clinical validity of the Intrinsic LifeSciences (ILS) Intrinsic Hepcidin IDx™ Test in the diagnosis and manag...

Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?

Vitamin B12 is an essential nutrient for normal DNA-synthesis and must be supplied by animal products. Vitamin B12 deficiency may cause anemia and irreverible neurological damage. Laborato...

PI EGFRvIII Peptide Vaccination After Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas

This is a research study of patients with diffuse intrinsic pontine gliomas. We hope to learn about the safety and efficacy of treating pediatric diffuse intrinsic pontine glioma patients...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

INTRINSIC RV - Inhibition of Unnecessary RV Pacing With AV Search Hysteresis in ICDs

INTRINSIC RV is a two-armed randomized trial that will compare the effects of innovative dual-chamber pacing with AV Search Hysteresis to standard VVI among ICD patients.

Companies [1323 Associated Companies listed on BioPortfolio]

Intrinsic Therapeutics, Inc.

Intrinsic Therapeutics is dedicated to treating soft-tissue injuries of the spine. Intrinsic's Barricaid anular reconstructive products are used during discectomy to definitively close defects in the ...

Cedilla Therapeutics

Cedilla Therapeutics is discovering and exploiting unique insights into protein stability. Cedilla’s integrated, multi-faceted approach has the potential to broaden the reach...

Intrinsic Bioprobes, Inc.

Intrinsic LifeSciences

Intrinsic LifeSciences, The BioIron Company™, is a privately held California-based company focused on developing innovative tests that help improve the diagnosis and treatmen...

AGY Therapeutics Incorporated

AGY is an emerging biopharmaceutical company, discovering and developing novel treatments for diseases of the nervous system. AGY scientists have established and utilized a unique mechanism-based appr...

More Information about "Intrinsic Therapeutics, Inc." on BioPortfolio

We have published hundreds of Intrinsic Therapeutics, Inc. news stories on BioPortfolio along with dozens of Intrinsic Therapeutics, Inc. Clinical Trials and PubMed Articles about Intrinsic Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intrinsic Therapeutics, Inc. Companies in our database. You can also find out about relevant Intrinsic Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Corporate Database Quicklinks

Searches Linking to this Company Record